Van Le L - Search Results

1

Genome-wide association study evaluating single-nucleotide polymorphisms and outcomes in patients with advanced stage serous ovarian or primary peritoneal cancer: An NRG Oncology/Gynecologic Oncology Group study.

Moore KN, Tritchler D, Kaufman KM, Lankes H, Quinn MCJ; Ovarian Cancer Association Consortium; Van Le L, Berchuck A, Backes FJ, Tewari KS, Lee RB, Kesterson JP, Wenham RM, Armstrong DK, Krivak TC, Bookman MA, Birrer MJ. Moore KN, et al. Among authors: van le l. Gynecol Oncol. 2017 Nov;147(2):396-401. doi: 10.1016/j.ygyno.2017.08.024. Epub 2017 Sep 19. Gynecol Oncol. 2017. PMID: 28935272 Free PMC article.

2

Lymph node metastases and prognosis in patients with stage IA2 cervical cancer.

Buckley SL, Tritz DM, Van Le L, Higgins R, Sevin BU, Ueland FR, DePriest PD, Gallion HH, Bailey CL, Kryscio RJ, Fowler W, Averette H, van Nagell JR Jr. Buckley SL, et al. Among authors: van le l, van nagell jr jr. Gynecol Oncol. 1996 Oct;63(1):4-9. doi: 10.1006/gyno.1996.0268. Gynecol Oncol. 1996. PMID: 8898159

3

Prolonged oral etoposide in recurrent or advanced squamous cell carcinoma of the cervix: a gynecologic oncology group study.

Rose PG, Blessing JA, Van Le L, Waggoner S. Rose PG, et al. Among authors: van le l. Gynecol Oncol. 1998 Aug;70(2):263-6. doi: 10.1006/gyno.1998.5097. Gynecol Oncol. 1998. PMID: 9740702 Clinical Trial.

4

A phase II trial of anastrozole in advanced recurrent or persistent endometrial carcinoma: a Gynecologic Oncology Group study.

Rose PG, Brunetto VL, VanLe L, Bell J, Walker JL, Lee RB. Rose PG, et al. Gynecol Oncol. 2000 Aug;78(2):212-6. doi: 10.1006/gyno.2000.5865. Gynecol Oncol. 2000. PMID: 10926805 Clinical Trial.

5

Gemcitabine as a single-agent treatment for ovarian cancer.

Fowler WC Jr, Van Le L. Fowler WC Jr, et al. Among authors: van le l. Gynecol Oncol. 2003 Aug;90(2 Pt 2):S21-3. doi: 10.1016/s0090-8258(03)00340-8. Gynecol Oncol. 2003. PMID: 12928002 Review.

6

Uterine serous carcinoma: a comparison of therapy for advanced-stage disease.

Gehrig PA, Morris DE, Van Le L. Gehrig PA, et al. Among authors: van le l. Int J Gynecol Cancer. 2004 May-Jun;14(3):515-20. doi: 10.1111/j.1048-891x.2004.14313.x. Int J Gynecol Cancer. 2004. PMID: 15228426

7

The role of optimal debulking in advanced stage serous carcinoma of the uterus.

Moller KA, Gehrig PA, Van Le L, Secord AA, Schorge J. Moller KA, et al. Among authors: van le l. Gynecol Oncol. 2004 Jul;94(1):170-4. doi: 10.1016/j.ygyno.2004.03.040. Gynecol Oncol. 2004. PMID: 15262137

8

Association between uterine serous carcinoma and breast cancer.

Gehrig PA, Bae-Jump VL, Boggess JF, Groben PA, Fowler WC Jr, Van Le L. Gehrig PA, et al. Among authors: van le l. Gynecol Oncol. 2004 Jul;94(1):208-11. doi: 10.1016/j.ygyno.2004.04.009. Gynecol Oncol. 2004. PMID: 15262144

9

An assessment of age and other factors influencing protocol versus alternative treatments for patients with epithelial ovarian cancer referred to member institutions: a Gynecologic Oncology Group study.

Moore DH, Kauderer JT, Bell J, Curtin JP, Van Le L. Moore DH, et al. Among authors: van le l. Gynecol Oncol. 2004 Aug;94(2):368-74. doi: 10.1016/j.ygyno.2004.05.033. Gynecol Oncol. 2004. PMID: 15297174

10

Consolidation therapy with weekly paclitaxel infusion in advanced epithelial ovarian cancer and primary peritoneal cancer: an extended follow-up.

Skinner EN, Boruta DM, Gehrig PA, Boggess JF, Fowler WC Jr, Van Le L. Skinner EN, et al. Among authors: van le l. Gynecol Oncol. 2005 Jul;98(1):59-62. doi: 10.1016/j.ygyno.2005.04.004. Gynecol Oncol. 2005. PMID: 15913741

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

105 results

Search Page

Filters